Featured Research

from universities, journals, and other organizations

Pilot study looks at medication safety in U.S. homes

Date:
October 17, 2011
Source:
American Academy of Pediatrics
Summary:
Nearly 30 percent of homes with young children have acetaminophen products stored unsafely, and nearly all homes included at least one expired medication, according to a new U.S. study.

Nearly 30 percent of homes with young children have acetaminophen products stored unsafely, and nearly all homes included at least one expired medication, according to a research abstract presented Oct. 17 at the American Academy of Pediatrics (AAP) National Conference and Exhibition in Boston.

Children under age 6 have the highest rate of unintentional poisoning, and acetaminophen is the leading cause of acute liver failure in the U.S. In the pilot study, "Acetaminophen and Expired Mediation Storage in the Home," researchers sought to determine whether or not acetaminophen was being stored unsafely in American homes, and whether unexpired medication was available.

The medication and storage practices of 24 families with children ages 2 to 6 were observed and documented, including where and how their medications were stored, if these medications contained acetaminophen, and whether they were expired. Safe storage was defined as medications placed above 5 feet, or below 5 feet and locked.

Acetaminophen was found in 23 of the 24 homes, and all homes had at least one expired medication. A total of 22 percent (174 of 799) of all medications and 30 percent (30 of 99) of acetaminophen-containing medications were stored unsafely.

"Acetaminophen is highly toxic when taken above therapeutic levels, and the hazards of consuming expired medications are unknown," said lead study author Lindsey Asti, of the Research Institute at Nationwide Children's Hospital. "The improper storage of these products is a concern for homes with young children because unfortunately, the rate of unintentional poisonings in this population is high."


Story Source:

The above story is based on materials provided by American Academy of Pediatrics. Note: Materials may be edited for content and length.


Cite This Page:

American Academy of Pediatrics. "Pilot study looks at medication safety in U.S. homes." ScienceDaily. ScienceDaily, 17 October 2011. <www.sciencedaily.com/releases/2011/10/111017092039.htm>.
American Academy of Pediatrics. (2011, October 17). Pilot study looks at medication safety in U.S. homes. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2011/10/111017092039.htm
American Academy of Pediatrics. "Pilot study looks at medication safety in U.S. homes." ScienceDaily. www.sciencedaily.com/releases/2011/10/111017092039.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins